Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing – NDTV
- Covaxin Phase 1 Trial Clears Lancet Review, Phase 3 Trial Ongoing NDTV
- 15 lakh vaccinated in Week 1; Covaxin now in 7 more states The Indian Express
- Seven more states to administer Covaxin from next week: Health Ministry Financial Express
- Bharat Biotech’s Covaxin led to tolerable safety outcomes, enhanced immune responses: Lancet Times Now
- India’s Vaccine Diplomacy Hits Hurdle as Covaxin’s Lack of Efficacy Data Gives Pause to Receiving Nat… News18
- View Full coverage on Google News